Skip to content
Open access

Epstein-Barr virus-associated chromatin activation and enhancer engagement in T/NK-cell lymphoproliferative diseases.

Sep 2026 · Blood · 0 citations
Medicine

TL;DR

A model in which EBV contributes to oncogenic transcriptional programs in these diseases by coupling three-dimensional chromatin reorganization and regulatory element activation to physical interactions with the host genome is supported.

Abstract

Epstein-Barr virus (EBV) infects many people and causes T-cell and natural killer (NK)-cell disorders, such as chronic active EBV disease and extranodal NK/T-cell lymphoma, which are aggressive and lack a common genetic driver. This suggests that virus-associated, non-genetic mechanisms contribute to disease. We studied primary T cells, NK cells, Epstein-Barr virus-positive cell lines derived from these disorders, virus-negative controls, and clinical chronic active EBV disease samples. Using genome-wide and single-cell multiome approaches, we examined three-dimensional chromatin organization, histone modifications, viral-host chromatin proximity, regulatory element activity, and transcription. EBV-positive lines shared a chromatin compartment pattern distinct from primary and virus-negative cancer cells. Regions that changed from inactive to active chromatin states showed increased activating histone marks and higher expression of nearby genes. EBV-interacting regions were enriched in inactive chromatin and inactive-to-active shifting regions, and contained activated promoters and enhancers associated with increased expression of neighboring genes in both T-cell and NK-cell backgrounds. Locus-level analyses identified CACNA2D1 and RGS1 as representative target genes with chromatin activation, and knockdown of each gene impaired cell growth in EBV-positive lines. Single-cell multiome profiling of clinical chronic active EBV disease samples identified EBV read-positive T-cell or NK-cell populations consistent with independently defined infected lineages and validated epigenomic and transcriptional rewiring at EBV-interacting regions. These findings support a model in which EBV contributes to oncogenic transcriptional programs in these diseases by coupling three-dimensional chromatin reorganization and regulatory element activation to physical interactions with the host genome.

Read PDF

Similar papers

Open access Sep 2026

A Human Genome-wide CRISPR-Cas9 Screen Reveals Host Factors That Support Epstein-Barr Virus B cell infection

A human genome-wide CRISPR-Cas9 screen uncovered entire pathways B-cell signaling, actin cytoskeleton remodeling, and nuclear import as essential for infection, expanding the known host-dependency landscape well beyond entry receptors.

Hong-Bo Wang, Y. Y. Yeo, Chong Wang et al. · 0 citations
Review Open access Nov 2026

Viral states and immune competence in Epstein–Barr virus-positive diffuse large B-cell lymphoma: conditions for therapeutic targeting

Epstein–Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) exhibits distinct viral expression, antigen-presentation and immune states that shape therapeutic opportunities. Malignant-cell viral attribution anchors diagnosis, while therapeutic activity depends on the target and mechanism being engaged. This...

Xin-Zhu Tang, Qiu-Hui Wu, He Li et al. · 0 citations
Open access Nov 2026

T/NK-cell remodeling and IFN-responsive myeloid activation delineate immunometabolic risk profiles in chronic active Epstein-Barr virus disease

Chronic active Epstein-Barr virus disease (CAEBV) is a rare EBV-associated T/NK-cell lymphoproliferative disorder characterized by persistent viral infection, systemic inflammation, and highly variable clinical courses. Patients may develop HLH-like hyperinflammation, severe organ involvement, lymphoma transformati...

Yue Cao, Zhe Zhou, Sheng-Lei Yu et al. · 0 citations
Review Sep 2026

Lifelong Epstein-Barr virus persistence as a stress test of ageing immune surveillance: from infectious mononucleosis to chronic active EBV disease and virus-associated malignancy.

Epstein-Barr virus (EBV) infects most humans and persists lifelong within a dynamic equilibrium maintained by B-cell latency, cytotoxic T-cell control, NK-cell surveillance and humoral immunity. Ageing can remodel this equilibrium through thymic involution, contraction of the naive T-cell pool, accumulation of late-dif...

Yue Cao, Yan Liang, Chen-Xi Zhao et al. · 0 citations
Open access Oct 2026

Cell-Sorted EBV PCR Identifies Lineage Shift and Guides Management After Hematopoietic Cell Transplantation for Pediatric EBV-Positive T/NK-Cell Lymphoid Neoplasia: A Case Series.

Epstein-Barr virus (EBV)-positive T/natural killer (NK)-cell lymphoid neoplasms, including chronic active EBV disease and EBV-positive T/NK-cell leukemias and lymphomas, are rare, aggressive disorders for which allogeneic hematopoietic cell transplantation (alloHCT) is the only established curative therapy. After alloH...

A. M. Quintero, Monica Bhatia, Diane M. George et al. · 0 citations
Open access Sep 2026

The influence of Epstein-Barr virus in the microenvironment of classic Hodgkin lymphoma: A focus on T-cells and macrophages

Background The prominent immune landscape in classic Hodgkin lymphoma is an essential tool to understand the pathogenesis of the disease. Objective The aim of this study was to evaluate the influence of the Epstein-Barr virus on the frequency and spatial distribution of lymphoid T-cells and macrophages in the immune mi...

Ana Claudia Frota Melo, V. Buccheri, J. Barbosa et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.